News

On Wednesday, the New York Attorney General, Letitia James, filed a lawsuit against Zelle, alleging that the payment platform failed to implement crucial safety measures, allowing fraudsters to

General Dynamics Corp.’s (GD) business unit, Electric Boat, recently clinched a modification contract involving submarines. The award has been offered by the Naval Sea Systems Command, Washington,

Petroleo Brasileiro S.A., or Petrobras PBR, announced second-quarter earnings per ADS of 64 cents, missing the Zacks Consensus Estimate of 70 cents. The underperformance can be attributed to lower

Nyxoah NYXH recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apnea (OSA). Featuring a leadless, battery-free design powered by an

Cardinal Health CAH recently announced a definitive agreement to acquire Solaris Health, the nation’s largest urology management services organization (MSO), in a deal valued at $2.4 billion. It

Biotech giant Regeneron’s (REGN) performance has been pretty ho-hum in the year so far. While Eylea sales continue to be under pressure, affecting the top line, the company finally managed to post

Nice NICE is benefiting from the continued strength of its cloud business, expansion of its customer base, and AI-powered solutions. Increased adoption of its CXone platform saw large enterprises

MasTec, Inc. MTZ delivered a strong second-quarter 2025, with revenue up 20% year over year to a record $3.54 billion and earnings per share of $1.49, beating consensus by 5.7%. The Communications

BJ's Wholesale Club (BJ) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus outlook

For July, Robinhood Markets, Inc. HOOD reported an increase in equity, options and crypto Daily Average Revenue Trades (DARTs) from the year-ago period. Equity DARTs in July were 2.7 million

PPG Industries, Inc. PPG is benefiting from cost discipline, acquisitions and pricing actions amid headwinds from demand weakness, especially in Europe. Its second-quarter adjusted earnings of $2.22

For an average investor, high-yield bond mutual funds are the best to invest in bonds rated below investment grade, popularly known as junk bonds. This is because these funds hold a wide range of

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 15th:

Everus Construction Group, Inc. ECG: This company which provides a full spectrum

Trinity Biotech plc TRIB announced compelling positive clinical trial results with respect to its next-generation continuous glucose monitoring (CGM) technology, CGM , on Tuesday. The trial data

AvalonBay Communities AVB is well-poised to gain from healthy renter demand for its residential properties in the high barrier-to-entry regions of the United States. The company’s efforts to

Welltower Inc.’s WELL senior housing operating (SHO) portfolio is well-poised to benefit from an aging population and a rise in healthcare expenditure by senior citizens. Moreover, favorable

Unum Group UNM holds the top position in the U.S. disability income market and ranks second in voluntary business. Unum's conservative pricing and reservation practices have contributed to overall

AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 43% of AstraZeneca‘s total revenues) rose 18% in the second quarter of 2025, generating $6.3

The Q2 earnings season remains robust and continues to improve, with an above-average share of companies topping estimates and outlooks strengthening for both the current and upcoming periods. Among

Tourmaline Bio, Inc. (TRML) closed the last trading session at $22.39, gaining 20.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Shares of Passage Bio, Inc. (PASG) have gained 31.5% over the past four weeks to close the last trading session at $7.59, but there could still be a solid upside left in the stock if short-term

Shares of Harrow (HROW) have gained 10.7% over the past four weeks to close the last trading session at $40.01, but there could still be a solid upside left in the stock if short-term price targets

Shares of Astria Therapeutics, Inc. (ATXS) have gained 8.3% over the past four weeks to close the last trading session at $6.76, but there could still be a solid upside left in the stock if

Ardmore Shipping (ASC) closed the last trading session at $10.49, gaining 4.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall